Skip to main content
Nature Communications logoLink to Nature Communications
. 2023 Jul 19;14:4341. doi: 10.1038/s41467-023-40050-1

Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT

Richard Hill 1,2,3, Patricia A Madureira 2, Bibiana Ferreira 2, Inês Baptista 2, Susana Machado 2, Laura Colaҫo 2, Marta dos Santos 2, Ningshu Liu 4, Ana Dopazo 5, Selma Ugurel 6, Angyal Adrienn 7, Endre Kiss-Toth 7, Murat Isbilen 8, Ali O Gure 8, Wolfgang Link 1,2,9,
PMCID: PMC10356827  PMID: 37468494

Retraction to: Nature Communications 10.1038/ncomms14687, published online 09 March 2017

The authors have retracted this article as it has come to their attention that several images were inappropriately processed and duplicated in multiple figures. In particular, the data were duplicated, and in some cases inverted, across several panels in Figures 2c, 2b, 3d and Supplementary Figure 5. Erroneous data were also included in Figure 2e, Supplementary Figure 1 and Supplementary Figure 8. We apologize to the scientific community for any confusion this article may have caused. Richard Hill, Patricia Madureira, Bibiana I. Ferreira, Susana Machado, Ana Dopazo, Selma Ugurel, Endre Kiss-Toth, Murat isbilen and Wolfgang Link agree with this retraction. Inês Baptista, Laura Colaço, Marta dos Santos, Ningshu Liu, Angyal Adrienn and Ali O. Gure have not responded to correspondence from the Publisher about this retraction.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES